Bioxyne Limited (ASX:BXN)
Australia
· Delayed Price · Currency is AUD 0.0400
0.00 (0.00%)
Jul 4, 2025, 3:19 PM AEST
Bioxyne Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Operating Revenue | 17.25 | 9.33 | 5.15 | 0.46 | 2.11 | 2.26 | Upgrade
|
Other Revenue | 0.08 | 0.32 | 0.14 | - | 0.09 | 0.08 | Upgrade
|
| 17.33 | 9.64 | 5.3 | 0.46 | 2.2 | 2.34 | Upgrade
| |
Revenue Growth (YoY) | 167.45% | 81.97% | 1042.88% | -78.97% | -5.61% | 6.03% | Upgrade
|
Cost of Revenue | 9.24 | 5.93 | 3.73 | 0.33 | 1.25 | 1.09 | Upgrade
|
Gross Profit | 8.09 | 3.72 | 1.57 | 0.13 | 0.95 | 1.24 | Upgrade
|
Selling, General & Admin | 3.89 | 3.88 | 2.69 | 0.49 | 1.19 | 1.35 | Upgrade
|
Research & Development | 0.48 | 0.72 | - | - | 0.09 | 0.13 | Upgrade
|
Operating Expenses | 5.14 | 4.85 | 3.38 | 0.59 | 1.32 | 1.55 | Upgrade
|
Operating Income | 2.95 | -1.13 | -1.82 | -0.45 | -0.37 | -0.31 | Upgrade
|
Interest Expense | -0.06 | - | - | - | -0 | -0.01 | Upgrade
|
Interest & Investment Income | 0.02 | 0.02 | 0 | - | 0.02 | 0.04 | Upgrade
|
Currency Exchange Gain (Loss) | -0.1 | - | 0.04 | 0 | -0.03 | 0.02 | Upgrade
|
Other Non Operating Income (Expenses) | -0.24 | -0.21 | -0.04 | -0 | -0.1 | -0.13 | Upgrade
|
EBT Excluding Unusual Items | 2.56 | -1.32 | -1.82 | -0.45 | -0.5 | -0.38 | Upgrade
|
Impairment of Goodwill | - | -11.57 | - | - | - | -0.15 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.08 | -0.08 | - | - | - | - | Upgrade
|
Asset Writedown | - | - | -0.1 | -0.04 | - | -0.06 | Upgrade
|
Pretax Income | 2.48 | -12.97 | -1.92 | -0.49 | -0.5 | -0.59 | Upgrade
|
Earnings From Continuing Operations | 2.48 | -12.97 | -1.92 | -0.49 | -0.5 | -0.59 | Upgrade
|
Earnings From Discontinued Operations | -0.35 | -0.53 | -0.05 | - | - | - | Upgrade
|
Net Income to Company | 2.13 | -13.5 | -1.96 | -0.49 | -0.5 | -0.59 | Upgrade
|
Minority Interest in Earnings | 0.11 | 0.18 | 0.02 | - | - | - | Upgrade
|
Net Income | 2.24 | -13.33 | -1.94 | -0.49 | -0.5 | -0.59 | Upgrade
|
Net Income to Common | 2.24 | -13.33 | -1.94 | -0.49 | -0.5 | -0.59 | Upgrade
|
Shares Outstanding (Basic) | 2,003 | 1,930 | 1,344 | 732 | 640 | 640 | Upgrade
|
Shares Outstanding (Diluted) | 2,028 | 1,930 | 1,344 | 732 | 640 | 640 | Upgrade
|
Shares Change (YoY) | 6.63% | 43.61% | 83.52% | 14.42% | - | - | Upgrade
|
EPS (Basic) | 0.00 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
EPS (Diluted) | 0.00 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
Free Cash Flow | 0.14 | -3.74 | -1.19 | -0.57 | 0.05 | 0.01 | Upgrade
|
Free Cash Flow Per Share | - | -0.00 | -0.00 | -0.00 | - | - | Upgrade
|
Gross Margin | 46.66% | 38.53% | 29.55% | 29.10% | 43.13% | 53.11% | Upgrade
|
Operating Margin | 17.00% | -11.75% | -34.32% | -97.72% | -16.97% | -13.37% | Upgrade
|
Profit Margin | 12.91% | -138.19% | -36.61% | -106.55% | -22.49% | -25.40% | Upgrade
|
Free Cash Flow Margin | 0.82% | -38.77% | -22.45% | -122.27% | 2.41% | 0.63% | Upgrade
|
EBITDA | 3.37 | -1.08 | -1.71 | -0.42 | -0.36 | -0.29 | Upgrade
|
EBITDA Margin | 19.44% | -11.22% | -32.25% | -91.09% | -16.17% | -12.31% | Upgrade
|
D&A For EBITDA | 0.42 | 0.05 | 0.11 | 0.03 | 0.02 | 0.02 | Upgrade
|
EBIT | 2.95 | -1.13 | -1.82 | -0.45 | -0.37 | -0.31 | Upgrade
|
EBIT Margin | 17.00% | -11.75% | -34.32% | -97.72% | -16.97% | -13.37% | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.